Vendor, San Diego, CA
Mapp Biopharmaceutical, Inc.
UEI M9V9QTHR1H28, CAGE 417U0
13 awards and $134,279,350 obligated between January 9, 2024 and September 30, 2026, 69% under full and open competition, against 1.2 offers on average where reported. 2 of the awards trace back to a SAM.gov solicitation on this site.
Sells to
Awarding agencies by dollars.
| Office of Assistant Secretary for Preparedness and Response | $134,097,547 |
| Defense Health Agency | $181,803 |
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $136,148,104 |
| In-Vitro Diagnostic Substance ManufacturingNAICS 325413 | $191,500 |
| Professional, Scientific, and Technical ServicesNAICS 541711 | $0 |
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | $0 |
| Testing Laboratories and ServicesNAICS 541380 | -$9,697 |
| Research and Development in the Social Sciences and HumanitiesNAICS 541720 | -$2,050,557 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 9 |
| Not Competed Under SAP | 4 |
| Definitive Contract | 8 |
| Delivery Order | 3 |
Hear when Mapp Biopharmaceutical, Inc. wins an award and when a contract it holds is about to end.Follow it
Contracts ending soon
Contracts Mapp Biopharmaceutical, Inc. holds whose performance ends in the next 19 months, by published end date. Each one is a recompete to prepare for.
- Ending
- 1
- Obligated so far
- -$2,050,557
- Soonest
- December 31, 2026
The 1 contract, the office behind each one and the dates are in the workspace. See them
Competes with
Vendors selling research and development in biotechnology (except nanobiotechnology) to Office of Assistant Secretary for Preparedness and Response, by dollars.
| Advanced Technology InternationalSummerville, SC | $2,764,576,471 |
| Albert B. Sabin Vaccine Institute, Inc. (The)Washington, DC | $356,898,734 |
| Amgen USA Inc.Thousand Oaks, CA | $345,705,117 |
| Start2 Group, Inc.Cambridge, MA | $227,139,021 |
| Siga Technologies, Inc.New York, NY | $177,835,284 |
| Shionogi Inc.Florham Park, NJ | $156,109,904 |
Solicitations it won
SAM.gov opportunities whose award USAspending attributes to this vendor.
- human-derived monoclonal antibodies (mAbs) and viral recombinant antigens (Ags)
Defense Health Agency (Dha), Army Med Res Acq Activity
Award noticeNAICS 541714Anywhere in the USHT9425-25-D-0009Awarded to Mapp Biopharmaceutical, Inc. for $2,000,000
Posted Jun 4, 2025 - Office of Biomedical Advanced Research and Development Authority Broad Agency Announcement (BAA)
Office of Assistant Secretary for Preparedness and Response, Aspr Administration for Strategic Preparedness and Response
Award noticeNAICS 541715San Diego, CA75A50124C00003Awarded to Mapp Biopharmaceutical, Inc. for $38,199,745
Posted Mar 21, 2024
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75A50122C00061Definitive Contract, May 9, 2024, Full and Open Competition, 2 offers | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | Procurement of Therapeutics for Ebola, Sudan and Marburg VirusesNAICS 541714, PSC 6505 | $86,076,373 |
| 75A50122C00076Definitive Contract, March 8, 2024, Full and Open Competition, 1 offers | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | This Cost-Plus-Fixed-Fee Contract with Mapp Biopharmaceutical, INC. (Mapp or Contractor) Is for the Development of Mapp?s Therapeutic IntervNAICS 541714, PSC AN13 | $44,335,303 |
| 75A50124C00003Definitive Contract, March 19, 2024, Full and Open Competition, 1 offersSolicitation | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | Development of Medical Countermeasures Through Planned Clinical Trials and Outbreak PreparednessNAICS 541714, PSC AJ11 | $5,626,972 |
| HT942525F0237Delivery Order, June 5, 2025, Not Competed Under SAP | Army Med Res Acq ActivityDefense Health Agency | Antibody & Antigen SupplyNAICS 325413, PSC 6550 | $110,500 |
| 75A50120C00198Definitive Contract, June 24, 2024, Full and Open Competition, 1 offers | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | The Purpose of This Is to Update Articles B.2, B.3, F.2(A) and Article G.1, G.5, Extend Pop for Clin 0001, Clin 0004, Clin 0005, and ProvideNAICS 541714, PSC 6505 | $109,456 |
| HT942525FE048Delivery Order, September 16, 2025, Not Competed Under SAP | Army Med Res Acq ActivityDefense Health Agency | Human-Derived Monoclonal Antibodies and Recombinant AntigensNAICS 325413, PSC 6550 | $60,500 |
| HT942626FE011Delivery Order, February 6, 2026, Not Competed Under SAP | Defense Health AgencyDefense Health Agency | Procurement of Human Derived Monoclonal Antibodies and AntigensNAICS 325413, PSC 6550 | $20,500 |
| 75A50118C00024Definitive Contract, January 9, 2024, Full and Open Competition, 1 offers | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | Advance MBP134, a Cocktail of Two Human Monoclonal Antibodies (MBP047 and MBP087), as a Potential Medical Countermeasure to Treat Active InfNAICS 541715, PSC AN13 | $0 |
| HHSO100201700023CDefinitive Contract, May 4, 2026, Full and Open Competition, 1 offers | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | Update Contracting Officer and Indirect RatesNAICS 541711, PSC AN13 | $0 |
| 75A50119D00018January 23, 2024, Full and Open Competition, 2 offers | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | NO-COST Modification Is to Transfer Government Furnished Property (Gfp) from Hhso100201900018c to 75A50122C00076.NAICS 541714, PSC AN13 | $0 |
| HT942525D0009May 29, 2025, Not Competed Under SAP, 1 offersSolicitation | Army Med Res Acq ActivityDefense Health Agency | Material Requirement for the Delivery of Antibody and Antigen Supply.NAICS 325413, PSC 6550 | $0 |
| W81XWH21C0121Definitive Contract, July 31, 2024, Full and Open Competition, 1 offers | Army Med Res Acq ActivityDefense Health Agency | Biopharmaceutical Cell CreationNAICS 541380, PSC AN13 | -$9,697 |
| HHSO100201600021CDefinitive Contract, July 10, 2024, Full and Open Competition, 1 offers | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | Support the Initiation, Maintenance, and Execution of a Zmapp Eap in the US and Africa, Including Clinical, Quality, Regulatory, and OperatiNAICS 541720, PSC AN12 | -$2,050,557 |
- Places of performance
- CaliforniaMaryland
- Product and service codes
- 6505 Drugs and BiologicalsAN13 Health R&D Services; Health Care Services; Experimental DevelopmentAJ11 General Science And Technology R&D Services; General Science And Technology; Basic Research6550 In Vitro Diagnostic Substances, Reagents, Test Kits and SetsAN12 Health R&D Services; Health Care Services; Applied Research
- Transactions
- 96 across 13 awards